Supply Chain Coordination and Influenza Vaccination

References

• Anderson R. M., May R. M.Infectious Diseases of Humans: Dynamics and Control (1991) (Oxford University Press)Crossref, Google Scholar
• Barnes-Schuster D., Bassok Y., Anupindi R. Coordination and flexibility in supply contracts with options. Manufacturing Service Oper. Management (2002) 4(3):171–207Link, Google Scholar
• Bauch C. T., Earn D. J. D. Vaccination and the theory of games. Proc. Nat. Acad. Sci. USA (2004) 101(36):13391–13394Crossref, Google Scholar
• Bernstein F., Federgruen A. Decentralized supply chains with competing retailers under demand uncertainty. Management Sci. (2005) 51(1):18–29Link, Google Scholar
• Brandeau M., Sainfort F., Pierskalla W. P.Operations Research and Health Care: A Handbook of Methods and Applications (2004) (Kluwer Academic Publishers, New York) Google Scholar
• Bush G. W. President outlines pandemic influenza preparations and response. (2005) . Retrieved January 22, 2006, http://www.whitehouse.gov/news/releases/2005/11/20051101-1.htmlGoogle Scholar
• Cachon G. P., Graves S., de Kok T. Supply chain coordination with contracts. Handbook in Operations Research and Management Science: Supply Chain Management (2003) (Elsevier, Amsterdam) 229–330Crossref, Google Scholar
• Cachon G. P., Lariviere M. A. Supply chain coordination with revenue sharing contracts. Management Sci. (2005) 51(1):30–44Link, Google Scholar
• Centers for Disease Control and Prevention Vaccine price list. (2005) . http://www.cdc.gov/nip/vfc/cdc_vac_price_list.htmGoogle Scholar
• Diekmann O., Heesterbeek J. A. P.Mathematical Epidemiology of Infectious Diseases (2000) (Wiley)Google Scholar
• Dietz K. The estimation of the basic reproduction number for infectious diseases. Statist. Methods in Medical Res. (1993) 2:23–41Crossref, Google Scholar
• Food and Drug Administration Biological product shortages. (2005) . http://www.fda.gov/cber/shortage/shortage.htm#fluGoogle Scholar
• Gani R., Hughes H., Fleming D., Griffin T., Medlock J., Leach S. Potential impact of antiviral drug use during influenza pandemic. Emerging Infectious Diseases (2005) 11(9):1355–1362Crossref, Google Scholar
• Gerdil C. The annual production cycle for influenza vaccine. Vaccine (2003) 21:1776–1779Crossref, Google Scholar
• Henig M., Gerchak Y. The structure of periodic review policies in the presence of random yield. Oper. Res. (1990) 38(4):634–643Link, Google Scholar
• Hill A. N., Longini I. M. The critical fraction for heterogeneous epidemic models. Math. Biosciences (2003) 181:85–106Crossref, Google Scholar
• Kaplan E. H., Craft D. L., Wein L. M. Emergency response to a smallpox attack: The case for mass vaccination. Proc. Nat. Acad. Sci. USA (2002) 99(16):10935–10940Crossref, Google Scholar
• Lariviere M., Magazine M., Tayur S., Ganeshan R. Supply chain contracting and coordination with stochastic demand. Quantitative Models of Supply Chain Management (1999) (Kluwer Academic Publishers)233–268Crossref, Google Scholar
• Longini I. M., Ackerman E., Elveback L. R. An optimization model for influenza A epidemics. Math. Biosciences (1978) 38:141–157Crossref, Google Scholar
• Longini I. M., Halloran M. E., Nizam A., Yang Y. Containing pandemic influenza with antiviral agents. Amer. J. Epidemiology (2004) 159(7):623–633Crossref, Google Scholar
• Longini I. M., Halloran M. E., Nizam A., Wolff M., Mendelman P. M., Fast P. E., Belshe R. B. Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: Implications for influenza epidemic control. Vaccine (2000) 18:1902–1909Crossref, Google Scholar
• Murray J. D.Mathematical Biology (1993) 2nd ed.(Springer, Heidelberg) Crossref, Google Scholar
• Nash J. F. Non-cooperative games. Ann. Math. (1951) 54:286–295Crossref, Google Scholar
• Nichol K. L., Margolis K. L., Wuorenma J., Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. New England J. Medicine (1994) 331(12):778–784Crossref, Google Scholar
• Palese P. Making better influenza virus vaccines. Emerging Infectious Diseases (2006) 12(1):61–65Crossref, Google Scholar
• Pasternack B. Optimal pricing and return policies for perishable commodities. Marketing Sci. (1985) 4(2):166–176Link, Google Scholar
• Pien H. Statement presented to Committee on Aging, United States Senate, by President and CEO, Chiron Corporation. (2004) . Retrieved January 22, 2006, http://aging.senate.gov/_files/hr133hp.pdfGoogle Scholar
• Pisano W. Keys to strengthening the supply of routinely recommended vaccines: View from industry. Clinical Infectious Diseases (2006) 42:S111–S117Crossref, Google Scholar
• Shih W. Optimal inventory policies when stockouts result from defective products. Internat. J. Production Res. (1980) 18(6):677–685Crossref, Google Scholar
• Silver E. A. Establishing the reorder quantity when the amount received is uncertain. INFOR (1976) 14:32–39Google Scholar
• Smith D. J., Lapedes A. S., de Jong J. C., Bestebroer T. M., Rimmelzwaan G. G., Osterhaus A. D. M. E., Fouchier R. A. M. Mapping the antigenic and genetic evolution of influenza virus. Science (2004) 305:371–376Crossref, Google Scholar
• Su X., Zenios S. Patient choice in kidney allocation: The role of the queueing discipline. Manufacturing Service Oper. Management (2004) 6(4):280–301Link, Google Scholar
• U.S. Department of Health and Human Services Secretary Thompson announces contract to secure future egg supply for flu vaccines. (2004) . Retrieved January 26, 2006, http://www.dhhs.gov/news/press/2004pres/20041109a.htmlGoogle Scholar
• U.S. Department of Health and Human Services HHS pandemic influenza plan: Supplement 6–vaccine distribution and use. (2005) . Retrieved January 26, 2006, http://www.dhhs.gov/pandemicflu/plan/Google Scholar
• U.S. General Accounting Office Flu vaccine: Supply problems heighten need to ensure access for high-risk people. (2001) . U.S. General Accounting Office Report to Congressional Requesters, GAO-01-624, Washington, D.C.Google Scholar
• Weniger B. G., Chen R. T., Jacobson S. H., Sewell E. C., Demon R., Livengood J. R., Orenstein W. A. Addressing the challenges to immunization practice with an economic algorithm for vaccine selection. Vaccine (1998) 16(9):1885–1897Crossref, Google Scholar
• Weycker D., Edelsberg J., Halloran M. E., Longini I. M., Nizam A., Ciuryla V., Oster G. Population-wide benefits of routine vaccination of children against influenza. Vaccine (2005) 23:1284–1293Crossref, Google Scholar
• World Health Organization Influenza vaccines. Weekly Epidemiological Record (2005) 80(33):277–287Google Scholar
• Wu J. T., Wein L. M., Perelson A. S. Optimization of influenza vaccine selection. Oper. Res. (2005) 53(3):456–476Link, Google Scholar
• Wysocki B., Lueck S. Margin of safety: Just-in-time inventories make U.S. vulnerable in a pandemic. Wall Street Journal (2006) 12(January):1Google Scholar
• Yadav P., Williams D. Value of creating a redistribution network for influenza vaccine in the U.S. (2005) Presentation at INFORMS 2006 Annual ConferenceSan FranciscoGoogle Scholar
• Yano C. A., Lee H. L. Lot sizing with random yields: A review. Oper. Res. (1995) 43(2):311–334Link, Google Scholar
• Zaric G. S., Brandeau M. L., Bravata D. M., Holty J-E. C., Wilhelm E. R., McDonald K. M., Owens D. K. Modeling the logistics of response to anthrax bioterrorism. (2006) . Working paper, Stanford University, Stanford, CAGoogle Scholar